astemizole has been researched along with Angina Pectoris, Variant in 1 studies
Astemizole: Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.
astemizole : A piperidine compound having a 2-(4-methoxyphenyl)ethyl group at the 1-position and an N-[(4-fluorobenzyl)benzimidazol-2-yl]amino group at the 4-position.
Angina Pectoris, Variant: A clinical syndrome characterized by the development of CHEST PAIN at rest with concomitant transient ST segment elevation in the ELECTROCARDIOGRAM, but with preserved exercise capacity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, S | 1 |
| Oka, H | 1 |
| Matunaga, K | 1 |
| Kubo, S | 1 |
| Asai, S | 1 |
| Miyahara, Y | 1 |
| Osaka, A | 1 |
| Kohno, S | 1 |
1 other study available for astemizole and Angina Pectoris, Variant
| Article | Year |
|---|---|
Astemizole-induced torsades de pointes in a patient with vasospastic angina.
Topics: Aged; Angina Pectoris, Variant; Anti-Allergic Agents; Astemizole; Coronary Vasospasm; Female; Humans | 1998 |